Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
BMC Medical Genetics|November 14, 2019
Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han populationKun Huang, Erqiang Hu, Wan Li, et al.Scientific Reports|December 20, 2016
Identification of cancer risk lncRNAs and cancer risk pathways regulated by cancer risk lncRNAs based on genome sequencing data in human cancersYiran Li, Wan Li, Binhua Liang, et al.International Journal of Molecular Sciences|February 11, 2023
Guiding Drug Repositioning for Cancers Based on Drug Similarity NetworksShimei Qin, Wan Li, Hongzheng Yu, et al.Molecular Biosystems|October 16, 2014
Identifying progression related disease risk modules based on the human subcellular signaling networksRuiqiang Xie, Hao Huang, Wan Li, et al.Biomed Research International|August 19, 2014
Identification of modules related to programmed cell death in CHD based on EHENXu Jia, Wan Li, Zhengqiang Miao, et al.Molecular Biosystems|September 24, 2013
Cancer-related marketing centrality motifs acting as pivot units in the human signaling network and mediating cross-talk between biological pathwaysWan Li, Lina Chen, Xia Li, et al.Bioscience Reports|January 11, 2020
A susceptibility biomarker identification strategy based on significantly differentially expressed ceRNA triplets for ischemic cardiomyopathyYuqing Zou, Yahui Wang, Zherou Rong, et al.Biology|September 23, 2022
Integrating Expression Data-Based Deep Neural Network Models with Biological Networks to Identify Regulatory Modules for Lung AdenocarcinomaLei Fu, Kai Luo, Junjie Lv, et al.BMC Medical Genomics|December 11, 2013
Unraveling the characteristics of microRNA regulation in the developmental and aging process of the human brainWeiguo Li, Lina Chen, Wan Li, et al.Plos One|March 20, 2014
Cancer-risk module identification and module-based disease risk evaluation: a case study on lung cancerXu Jia, Zhengqiang Miao, Wan Li, et al.Pageof 4